February 7, 2014
MediCortex is a privately held company founded in 2011 by Dr. Adrian Harel, an experienced neurobiologist with a track record in business management and leadership of early-stage drug discovery companies. His collaboration with renowned experts in medicinal chemistry promises to generate a successful pipeline of innovative molecules for the treatment of acute neurodegenerative disorders like TBI.
MediCortex is dedicated to drug discovery for traumatic brain injury (TBI) and stroke. MediCortex's strategy is to introduce, multi-functional compound that will address a number of pathways simultaneously.